Literature DB >> 25363395

Effects of miR-200c on the migration and invasion abilities of human prostate cancer Du145 cells and the corresponding mechanism.

Runlin Shi1, Haibing Xiao, Tao Yang, Lei Chang, Yuanfeng Tian, Bolin Wu, Hua Xu.   

Abstract

microRNAs (miRNAs) have played a key role in human tumorigenesis, tumor progression, and metastasis. On the one hand, miRNAs are aberrantly expressed in many types of human cancer; on the other hand, miRNAs can function as tumor suppressors or oncogenes that target many cancer-related genes. This study aimed to investigate the effects of miRNA-200c (miR-200c) on the biological behavior and mechanism of proliferation, migration, and invasion in the prostate cancer cell line Du145. In this study, Du145 cells were transfected with miR-200c mimics or negative control miR-NC by using an X-tremeGENE siRNA transfection reagent. The relative expression of miR-200c was measured by RT-PCR. The proliferation, migration, and invasion abilities of Du145 cells were detected by CCK8 assays, migration assays and invasion assays, respectively. The expressions of ZEB1, E-cadherin, and vimentin were observed by western blot. Results showed that DU145 cells exhibited a high expression of miR-200c compared with immortalized normal prostate epithelial cell RWPE-1. Du145 cells were then transfected with miR-200c mimics and displayed lower abilities of proliferation, migration, and invasion than those transfected with the negative control. The protein levels of ZEB1 and vimentin were expressed at a low extent in Du145 cells, which were transfected with miR-200c mimics; by contrast, E-cadherin was highly expressed. Hence, miR-200c could significantly inhibit the proliferation of the prostate cancer cell line Du145; likewise, miR-200c could inhibit migration and invasion by epithelial-mesenchymal transition.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25363395     DOI: 10.1007/s11684-014-0353-z

Source DB:  PubMed          Journal:  Front Med        ISSN: 2095-0217            Impact factor:   4.592


  35 in total

1.  miR-200c inhibits invasion and migration in human colon cancer cells SW480/620 by targeting ZEB1.

Authors:  Mian Ling Chen; Liu Sen Liang; Xiao Kang Wang
Journal:  Clin Exp Metastasis       Date:  2012-03-10       Impact factor: 5.150

Review 2.  Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis.

Authors:  Jing Yang; Robert A Weinberg
Journal:  Dev Cell       Date:  2008-06       Impact factor: 12.270

3.  A new regulatory loop in cancer-cell invasion.

Authors:  Oscar H Ocaña; M Angela Nieto
Journal:  EMBO Rep       Date:  2008-05-16       Impact factor: 8.807

Review 4.  Epithelial-mesenchymal transitions in development and disease.

Authors:  Jean Paul Thiery; Hervé Acloque; Ruby Y J Huang; M Angela Nieto
Journal:  Cell       Date:  2009-11-25       Impact factor: 41.582

5.  Overexpression of miR-200c induces chemoresistance in esophageal cancers mediated through activation of the Akt signaling pathway.

Authors:  Rie Hamano; Hiroshi Miyata; Makoto Yamasaki; Yukinori Kurokawa; Johji Hara; Jeong Ho Moon; Kiyokazu Nakajima; Shuji Takiguchi; Yoshiyuki Fujiwara; Masaki Mori; Yuichiro Doki
Journal:  Clin Cancer Res       Date:  2011-01-19       Impact factor: 12.531

Review 6.  Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits.

Authors:  Kornelia Polyak; Robert A Weinberg
Journal:  Nat Rev Cancer       Date:  2009-03-05       Impact factor: 60.716

7.  miR-200 regulates PDGF-D-mediated epithelial-mesenchymal transition, adhesion, and invasion of prostate cancer cells.

Authors:  Dejuan Kong; Yiwei Li; Zhiwei Wang; Sanjeev Banerjee; Aamir Ahmad; Hyeong-Reh Choi Kim; Fazlul H Sarkar
Journal:  Stem Cells       Date:  2009-08       Impact factor: 6.277

8.  The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44.

Authors:  Can Liu; Kevin Kelnar; Bigang Liu; Xin Chen; Tammy Calhoun-Davis; Hangwen Li; Lubna Patrawala; Hong Yan; Collene Jeter; Sofia Honorio; Jason F Wiggins; Andreas G Bader; Randy Fagin; David Brown; Dean G Tang
Journal:  Nat Med       Date:  2011-01-16       Impact factor: 53.440

9.  A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells.

Authors:  Ulrike Burk; Jörg Schubert; Ulrich Wellner; Otto Schmalhofer; Elizabeth Vincan; Simone Spaderna; Thomas Brabletz
Journal:  EMBO Rep       Date:  2008-05-16       Impact factor: 8.807

10.  TMPRSS2-ERG gene fusions induce prostate tumorigenesis by modulating microRNA miR-200c.

Authors:  J Kim; L Wu; J C Zhao; H-J Jin; J Yu
Journal:  Oncogene       Date:  2013-11-04       Impact factor: 9.867

View more
  11 in total

Review 1.  miRNA nanotherapeutics for cancer.

Authors:  Aditya Ganju; Sheema Khan; Bilal B Hafeez; Stephen W Behrman; Murali M Yallapu; Subhash C Chauhan; Meena Jaggi
Journal:  Drug Discov Today       Date:  2016-11-01       Impact factor: 7.851

2.  Demethylation drug 5-Aza-2'-deoxycytidine-induced upregulation of miR-200c inhibits the migration, invasion and epithelial-mesenchymal transition of clear cell renal cell carcinoma in vitro.

Authors:  Juan Jiang; B O Yi; Siqing Ding; Jian Sun; Wei Cao; Mengzi Liu
Journal:  Oncol Lett       Date:  2016-03-22       Impact factor: 2.967

3.  GSE1 predicts poor survival outcome in gastric cancer patients by SLC7A5 enhancement of tumor growth and metastasis.

Authors:  Keshuo Ding; Sheng Tan; Xing Huang; Xiaonan Wang; Xiaocan Li; Rong Fan; Yong Zhu; Peter E Lobie; Wenbin Wang; Zhengsheng Wu
Journal:  J Biol Chem       Date:  2018-01-24       Impact factor: 5.157

4.  MicroRNA-134 functions as a tumor suppressor gene in gastric cancer.

Authors:  Ze-An Qiu; Guo-Ping He
Journal:  Am J Transl Res       Date:  2016-10-15       Impact factor: 4.060

5.  Urine miR-21-5p and miR-200c-3p as potential non-invasive biomarkers in patients with prostate cancer.

Authors:  Raden Danarto; Indwiani Astuti; Rainy Umbas; Sofia Mubarika Haryana
Journal:  Turk J Urol       Date:  2019-11-29

6.  MicroRNA-200c-3p/ZEB2 loop plays a crucial role in the tumor progression of prostate carcinoma.

Authors:  Jiayi Zhang; Hengcheng Zhang; Yuan Qin; Chen Chen; Jie Yang; Ninghong Song; Min Gu
Journal:  Ann Transl Med       Date:  2019-04

Review 7.  Gene interference strategies as a new tool for the treatment of prostate cancer.

Authors:  Mariarosaria Boccellino; Concetta Alaia; Gabriella Misso; Alessia Maria Cossu; Gaetano Facchini; Raffaele Piscitelli; Lucio Quagliuolo; Michele Caraglia
Journal:  Endocrine       Date:  2015-06-07       Impact factor: 3.925

Review 8.  MicroRNAs as Guardians of the Prostate: Those Who Stand before Cancer. What Do We Really Know about the Role of microRNAs in Prostate Biology?

Authors:  Thomas Andl; Kavya Ganapathy; Alexia Bossan; Ratna Chakrabarti
Journal:  Int J Mol Sci       Date:  2020-07-07       Impact factor: 5.923

9.  miRNA-214-5p inhibits prostate cancer cell proliferation by targeting SOX4.

Authors:  Guangchi Xu; Yin Meng; Lihe Wang; Bo Dong; Feifei Peng; Songtao Liu; Shukui Li; Tao Liu
Journal:  World J Surg Oncol       Date:  2021-12-04       Impact factor: 2.754

10.  USP14 de-ubiquitinates vimentin and miR-320a modulates USP14 and vimentin to contribute to malignancy in gastric cancer cells.

Authors:  Ying Zhu; Yan Zhang; Zhenhua Sui; Yi Zhang; Min Liu; Hua Tang
Journal:  Oncotarget       Date:  2017-07-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.